ARKG vs. BOUT ETF Comparison
Comparison of ARK Genomic Revolution Multi-Sector ETF (ARKG) to Innovator IBD Breakout Opportunities ETF (BOUT)
ARKG
ARK Genomic Revolution Multi-Sector ETF
ARKG Description
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.
Grade (RS Rating)
Last Trade
$23.42
Average Daily Volume
2,187,233
34
BOUT
Innovator IBD Breakout Opportunities ETF
BOUT Description
The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock's recent "resistance level," with consideration for various market conditions. The fund is non-diversified. BOUT uses technical analysis to find stocks that are likely to breakout. The funds index relies on an algorithm that establishes a base price (a recent high) for each eligible security. The index then follows the trend for each stock. Selected stocks are ranked by a combination of relative strength and fundamental factors, and then weighted in fixed tiers according to this ranking. In addition, BOUT will move 50% of its portfolio into T-bills based on market signals: a rapid increase in either margin debt or overall stock prices, combined with slowing reversing momentum in the S&P 500. The T-bill position will remain in place until the S&P 500 falls by 50% or show indications of rising momentum. BOUT is rebalanced and reconstituted weekly after the close on Friday. The frequent rebalance schedule means the fund will be highly responsive to the technical factors that drive its strategy, but could also experience high turnover.Grade (RS Rating)
Last Trade
$40.67
Average Daily Volume
3,050
44
Performance
Period | ARKG | BOUT |
---|---|---|
30 Days | -0.57% | 10.23% |
60 Days | -7.63% | 10.93% |
90 Days | -13.18% | 11.26% |
12 Months | -15.16% | 34.57% |
1 Overlapping Holdings
Symbol | Grade | Weight in ARKG | Weight in BOUT | Overlap | |
---|---|---|---|---|---|
CDNA | D | 4.77% | 1.24% | 1.24% |
ARKG Overweight 33 Positions Relative to BOUT
Symbol | Grade | Weight | |
---|---|---|---|
TWST | D | 8.37% | |
RXRX | F | 7.42% | |
CRSP | D | 7.34% | |
ADPT | C | 5.03% | |
VCYT | B | 4.51% | |
SDGR | C | 4.14% | |
BEAM | D | 4.01% | |
NTLA | F | 3.89% | |
IONS | F | 3.85% | |
NTRA | B | 3.82% | |
NRIX | D | 3.78% | |
TXG | F | 3.56% | |
GH | B | 3.49% | |
ARCT | F | 3.19% | |
PSNL | D | 2.7% | |
ABSI | F | 2.19% | |
PACB | F | 2.16% | |
BFLY | B | 1.71% | |
VEEV | C | 1.7% | |
AMGN | D | 1.68% | |
ACCD | D | 1.47% | |
VRTX | F | 1.29% | |
ILMN | D | 1.25% | |
CERS | C | 1.18% | |
INCY | C | 1.11% | |
REGN | F | 0.92% | |
PRME | F | 0.9% | |
CMPS | F | 0.75% | |
MASS | F | 0.69% | |
QSI | C | 0.68% | |
EXAS | D | 0.65% | |
RPTX | F | 0.64% | |
MRNA | F | 0.01% |
ARKG Underweight 43 Positions Relative to BOUT
Symbol | Grade | Weight | |
---|---|---|---|
PACS | F | -4.48% | |
MS | A | -4.47% | |
LBRDK | C | -4.44% | |
NEM | D | -4.42% | |
VIK | B | -4.39% | |
EXPE | B | -4.28% | |
EQIX | A | -4.25% | |
AHR | A | -4.24% | |
IDCC | B | -4.01% | |
ETN | A | -3.82% | |
SPGI | C | -3.81% | |
EQH | B | -3.78% | |
CRM | B | -3.73% | |
BAH | F | -3.73% | |
DVA | B | -3.71% | |
PGR | A | -3.63% | |
CRDO | B | -2.87% | |
VRNS | D | -2.61% | |
ULS | B | -2.59% | |
IR | B | -2.49% | |
DT | C | -2.49% | |
NMIH | D | -2.44% | |
ONON | A | -2.35% | |
COLL | F | -2.23% | |
TSM | B | -1.31% | |
TBBK | B | -1.28% | |
NOW | A | -1.27% | |
SCCO | F | -1.22% | |
SN | D | -1.2% | |
TCOM | B | -1.14% | |
BEKE | D | -1.06% | |
ROAD | A | -0.45% | |
AXON | A | -0.43% | |
TPH | D | -0.42% | |
IBKR | A | -0.42% | |
CWAN | B | -0.42% | |
AVGO | D | -0.42% | |
ALKT | B | -0.42% | |
GMED | A | -0.41% | |
CORT | B | -0.41% | |
ACGL | D | -0.4% | |
PLMR | B | -0.39% | |
JD | D | -0.38% |
ARKG: Top Represented Industries & Keywords
BOUT: Top Represented Industries & Keywords